Pub. Date : 2007 Jun
PMID : 17555368
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | A Phase II trial of gemcitabine with the anti-EGFR antibody cetuximab resulted in a 1-year survival of 32%. | gemcitabine | epidermal growth factor receptor | Homo sapiens |
| 2 | A Phase I trial of gemcitabine with the EGFR/Her-2 inhibitor, lapatinib, is completed. | gemcitabine | epidermal growth factor receptor | Homo sapiens |